Terms ending in 2036
Every in-force patent on AstraZeneca AB's record whose computed term ends in 2036, whoever holds it now. Soonest term end first, then patent number.
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US 10,300,065 | Method of Treating or Prevention of Atherothrombotic Events in Patients with History of Myocardial Infarction In force · High confidence | AstraZeneca AB | In force | High confidence | |
| US 10,954,308 | Antibodies to Ticagrelor and Methods of Use In force · Medium confidence | MedImmune Limited | In force | Medium confidence | |
| US 9,982,061 | Antibodies to Ticagrelor and Methods of Use In force · High confidence | MedImmune Limited | In force | High confidence | |
| US 10,183,947 | Pyrazole Derivatives Useful as 5-Lipoxygenase Activating Protein (FLAP) Inhibitors In force · High confidence | AstraZeneca AB | In force | High confidence | |
| US 10,508,119 | Pyrazole Derivatives Useful as 5-Lipoxygenase Activating Protein (FLAP) Inhibitors In force · High confidence | AstraZeneca AB | In force | High confidence | |
| US 11,001,589 | Pyrazole Derivatives Useful as 5-Lipoxygenase Activating Protein (FLAP) Inhibitors In force · High confidence | AstraZeneca AB | In force | High confidence | |
| US 11,691,978 | Pyrazole Derivatives Useful as 5-Lipoxygenase Activating Protein (FLAP) Inhibitors In force · High confidence | AstraZeneca AB | In force | High confidence | |
| US 12,024,523 | Pyrazole Derivatives Useful as 5-Lipoxygenase Activating Protein (FLAP) Inhibitors In force · High confidence | AstraZeneca AB | In force | High confidence | |
| US 9,845,331 | Chemical Compounds In force · High confidence | AstraZeneca AB | In force | High confidence | |
| US 10,717,746 | Chemical Compounds In force · High confidence | AstraZeneca AB | In force | High confidence | |
| 24 more term ends in 2036 · Pro | |||||
10 of 34 patents shown. Soonest term end first, then patent number.
Pro members see all 34.
26 of these are in force and held by AstraZeneca AB.
Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.